# Apixaban Discontinuation Prior to Major Surgery

> **NCT02935751** · — · COMPLETED · sponsor: **Thomas Jefferson University** · enrollment: 130 (estimated)

## Conditions studied

- Hemorrhage
- Thromboembolism

## Interventions

- **OTHER:** Lab tests for plasma levels of apixaban and anti-10a factor

## Key facts

- **NCT ID:** NCT02935751
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2018-07
- **Final completion:** 2018-09
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2018-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02935751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02935751, "Apixaban Discontinuation Prior to Major Surgery". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT02935751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*